Ongoing treatment with inotropic drugs (not norepinephrine)
Central venous oxygen saturation (ScvO2) < 60% despite optimization of hematocrit and volume status
Need of renal replacement therapy
Ongoing bleeding
Patient or next of kin does not consent with study participation
